Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 291 results.
User Information
Export Records
  1. 1.   HLA-DPA1*02:01~B1*01:01 is a risk haplotype for primary sclerosing cholangitis mediating activation of NKp44+ NK cells
  2. Zecher, Britta F; Ellinghaus, David; Schloer, Sebastian; Niehrs, Annika; Padoan, Benedetta; Baumdick, Martin E; Yuki,Yuko; Martin, Maureen P; Glow, Dawid; Schröder-Schwarz, Jennifer; Niersch, Jennifer; Brias, Sébastien; Müller, Luisa M; Habermann, Robin; Kretschmer, Paul; Früh, Tristan; Dänekas, Janis; Wehmeyer, Malte H; Poch, Tobias; Sebode, Marcial; Ellinghaus, Eva; Degenhardt, Frauke; Körner, Christian; Hoelzemer, Angelique; Fehse, Boris; Oldhafer, Karl J; Schumacher, Udo; Sauter, Guido; Carrington,Mary; Franke, Andre; Bunders, Madeleine J; Christoph, Schramm; Altfeld, Marcus
  3. Gut. 2023, Oct 03;
  1. 2.   Kaposi's sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda
  2. Nalwoga, Angela; Roshan, Romin; Moore, Kyle; Marshall, Vickie; Miley, Wendell; Labo, Nazzarena; Nakibuule, Marjorie; Cose, Stephen; Rochford, Rosemary; Newton, Robert; Whitby,Denise
  3. Nature Communications. 2021, Dec 16; 12(1):
  1. 3.   Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers
  2. Jackson-Thompson, Belinda M.; Goguet, Emilie; Laing, Eric D.; Olsen, Cara H.; Pollett, Simon; Hollis-Perry, K. Monique; Maiolatesi, Santina E.; Illinik, Luca; Ramsey, Kathleen F.; Reyes, Anatalio E.; Alcorta, Yolanda; Wong, Mimi A.; Davies, Julian; Ortega, Orlando; Parmelee, Edward; Lindrose, Alyssa R.; Moser, Matthew; Graydon, Elizabeth; Letizia, Andrew G.; Duplessis, Christopher A.; Ganesan, Anuradha; Pratt, Kathleen P.; Malloy, Allison M.; Scott, David W.; Anderson,Steve; Snow, Andrew L.; Dalgard, Clifton L.; Powers,John; Tribble, David; Burgess, Timothy H.; Broder, Christopher C.; Mitre, Edward
  3. BMC infectious diseases. 2021, Jun 9; 21(1):
  1. 4.   Cutaneous barrier leakage and gut inflammation drive skin disease in Omenn Syndrome
  2. Rigoni, Rosita; Fontana, Elena; Dobbs, Kerry; Marrella, Veronica; Taverniti, Valentina; Maina, Virginia; Facoetti, Amanda; D'Amico, Giovanna; Al-Herz, Waleed; Cruz-Munoz, Mario Ernesto; Schuetz, Catharina; Gennery, Andrew R; Garabedian, Elizabeth K; Giliani, Silvia; Draper, Deborah; Dbaibo, Ghassan; Geha, Raif S; Meyts, Isabelle; Tousseyn, Thomas; Neven, Benedicte; Moshous, Despina; Fischer, Alain; Schulz, Ansgar; Finocchi, Andrea; Kuhns,Doug; Fink,Dani; Lionakis, Michail S; Swamydas, Muthulekha; Guglielmetti, Simone; Alejo, Julie; Myles, Ian A; Pittaluga, Stefania; Notarangelo, Luigi D; Villa, Anna; Cassani, Barbara
  3. The Journal of allergy and clinical immunology. 2020, NOV; 146(5): 1165-+.
  1. 5.   Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge
  2. Om, Kier; Paquin-Proulx, Dominic; Montero, Maria; Peachman, Kristina; Shen, Xiaoying; Wieczorek, Lindsay; Beck, Zoltan; Weiner, Joshua A.; Kim, Dohoon; Li, Yifan; Mdluli, Thembi; Shubin, Zhanna; Bryant, Christopher; Sharma, Vishakha; Tokarev, Andrey; Dawson, Peter; White, Yohann; Appelbe, Oliver; Klatt, Nichole R.; Tovanabutra, Sodsai; Estes, Jacob D.; Matyas, Gary R.; Ferrari, Guido; Alving, Carl R.; Tomaras, Georgia D.; Ackerman, Margaret E.; Michael, Nelson L.; Robb, Merlin L.; Polonis, Victoria; Rolland, Morgane; Eller, Michael A.; Rao, Mangala; Bolton, Diane L.
  3. PLOS PATHOGENS. 2020, SEP; 16(9): pii: e1008764.
  1. 6.   Opportunities, Barriers, and a Strategy for Overcoming Translational Challenges to Therapeutic Nucleic Acid Nanotechnology
  2. Afonin, Kirill A.; Dobrovolskaia,Marina; Church, George; Bathe, Mark
  3. ACS NANO. 2020, AUG 25; 14(8): 9221-9227.
  1. 7.   Immunotherapy with DNA vaccine and live attenuated rubella/SIV gag vectors plus early ART can prevent SIVmac251 viral rebound in acutely infected rhesus macaques
  2. Virnik, Konstantin; Rosati,Margherita; Medvedev, Alexei; Scanlan, Aaron; Walsh, Gabrielle; Dayton, Frances; Broderick, Kate E; Lewis, Mark; Bryson, Yvonne; Lifson,Jeffrey; Ruprecht, Ruth M; Felber,Barbara; Berkower, Ira
  3. PloS one. 2020, MAR 4; 15(3): e0228163.
  1. 8.   Interleukin 22 disrupts pancreatic function in newborn mice expressing IL-23
  2. Chen, Lili; Strohmeier, Valentina; He, Zhengxiang; Deshpande, Madhura; Catalan-Dibene, Jovani; Durum,Scott; Moran, Thomas M; Kraus, Thomas; Xiong, Huabao; Faith, Jeremiah J; Sodhi, Chhinder P; Hackam, David J; Lira, Sergio A; Furtado, Glaucia C
  3. Nature communications. 2019, Oct 04; 10(1): 4517.
  1. 9.   Vaccine protection against rectal acquisition of SIVmac239 in rhesus macaques
  2. Gonzalez-Nieto, Lucas; Castro, Isabelle M; Bischof, Georg F; Shin, Young C; Ricciardi, Michael J; Bailey, Varian K; Dang, Christine M; Pedreño-Lopez, Nuria; Magnani, Diogo M; Ejima, Keisuke; Allison, David B; Gil, Hwi Min; Evans, David T; Rakasz, Eva G; Lifson,Jeffrey; Desrosiers, Ronald C; Martins, Mauricio A
  3. PLoS pathogens. 2019, Sep 30; 15(9): e1008015.
  1. 10.   Adoptive lymphocyte transfer to an HIV-infected progressor from an elite controller
  2. Migueles, Stephen A.; Chairez, Cheryl; Lin, Siying; Cavil, Noah; Rosenthal, Danielle M.; Pooran, Milad; Natarajan,Ven; Rupert,Adam; Dewar,Robin; Rehman, Tauseef; Sherman,Brad; Adelsberger,Joe; Leitman, Susan F.; Stroncek, David; Morse, Caryn G.; Connors, Mark; Lane, H. Clifford; Kovacs, Joseph A.
  3. JCI INSIGHT. 2019, SEP 19; 4(18):
  1. 11.   Anti-drug Antibody Responses Impair Prophylaxis Mediated by AAV-Delivered HIV-1 Broadly Neutralizing Antibodies
  2. Gardner, Matthew R.; Fetzer, Ina; Kattenhorn, Lisa M.; Davis-Gardner, Meredith E.; Zhou, Amber S.; Alfant, Barnett; Weber, Jesse A.; Kondur, Hema R.; Martinez-Navio, Jose M.; Fuchs, Sebastian P.; Desrosiers, Ronald C.; Gao, Guangping; Lifson,Jeffrey; Farzan, Michael
  3. Molecular therapy : the journal of the American Society of Gene Therapy. 2019, Mar 6; 27(3): 650-660.
  1. 12.   Autoimmunity and Cancer, the Paradox Comorbidities Challenging Therapy in the Context of Preexisting Autoimmunity
  2. Valencia,Julio; Egbukichi, Nkolika; Erwin-Cohen,Rebecca
  3. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research. 2019, JAN 1; 39(1): 72-84.
  1. 13.   Roadmap and strategy for overcoming infusion reactions to nanomedicines
  2. Szebeni, Janos; Simberg, Dmitri; Gonzalez-Fernandez, Africa; Barenholz, Yechezkel; Dobrovolskaia,Marina
  3. Nature nanotechnology. 2018, Dec; 13(12): 1100-1108.
  1. 14.   IL-15/IL-15R alpha/CD80-expressing AML cell vaccines eradicate minimal residual disease in leukemic mice
  2. Shi, Yimin; Dincheva-Vogel, Lillie; Ayemoba, Charles E.; Fung, Jeffrey P.; Bergamaschi, Cristina; Pavlakis, George; Farzaneh, Farzin; Gaensler, Karin M. L.
  3. BLOOD ADVANCES. 2018, NOV 27; 2(22): 3177-3192.
  1. 15.   An Interleukin-23-Interleukin-22 Axis Regulates Intestinal Microbial Homeostasis to Protect from Diet-Induced Atherosclerosis
  2. Fatkhullina, Aliia R.; Peshkova, Iuliia O.; Dzutsev, Amiran; Aghayev, Turan; McCulloch, John A.; Thovarai,Vishal; Badger, Jonathan H.; Vats, Ravi; Sundd, Prithu; Tang, Hsin-Yao; Kossenkov, Andrew V.; Hazen, Stanley L.; Trinchieri, Giorgio; Grivennikov, Sergei I.; Koltsova, Ekaterina K.
  3. Immunity. 2018, NOV 20; 49(5): 943-+.
  1. 16.   Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severity
  2. Kumar, Pardeep; Kuhlmann, F. Matthew; Chakraborty, Subhra; Bourgeois, A. Louis; Foulke-Abel, Jennifer; Tumala, Brunda; Vickers, Tim J.; Sack, David A.; DeNearing, Barbara; Harro, Clayton D.; Wright, W. Shea; Gildersleeve, Jeffrey; Ciorba, Matthew A.; Santhanam, Srikanth; Porter, Chad K.; Gutierrez, Ramiro L.; Prouty, Michael G.; Riddle, Mark S.; Polino, Alexander; Sheikh, Alaullah; Donowitz, Mark; Fleckenstein, James M.
  3. JOURNAL OF CLINICAL INVESTIGATION. 2018, Aug 1; 128(8): 3298-3311.
  1. 17.   Safety Analysis of Leishmania Vaccine Used in a Randomized Canine Vaccine/Immunotherapy Trial
  2. Toepp, Angela; Larson, Mandy; Grinnage-Pulley, Tara; Bennett, Carolyne; Anderson, Michael; Parrish, Molly; Fowler, Hailie; Wilson, Geneva; Gibson-Corely, Katherine; Gharpure, Radhika; Cotter, Caitlin; Petersen, Christine
  3. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE. 2018 98(5): 1332-1338.
  1. 18.   Clinical Evaluation of Safety and Immunogenicity of PADRE-Cytomegalovirus (CMV) and Tetanus-CMV Fusion Peptide Vaccines With or Without PF03512676 Adjuvant
  2. La Rosa, C.; Longmate, J.; Lacey, S. F.; Kaltcheva, T.; Sharan, R.; Marsano, D.; Kwon, P.; Drake, J.; Williams, B.; Denison, S.; Broyer, S.; Couture, L.; Nakamura, R.; Kelsey, M. I.; Krieg, A. M.; Diamond, D. J.; Zaia, J. A.
  3. Journal of Infectious Diseases. 2012, Apr; 205(8): 1294-1304.
  1. 19.   Arlm1 is a male-specific modifier of astrocytoma resistance on mouse Chr 12
  2. Amlin-Van Schaick, J. C.; Kim, S.; DiFabio, C.; Lee, M. H.; Broman, K. W.; Reilly, K. M.
  3. Neuro-Oncology. 2012, Feb; 14(2): 160-174.
  1. 20.   Ifih1 Gene Dose Effect Reveals MDA5-Mediated Chronic Type I IFN Gene Signature, Viral Resistance, and Accelerated Autoimmunity
  2. Crampton, S. P.; Deane, J. A.; Feigenbaum, L.; Boll, S.
  3. Journal of Immunology. 2012, Feb; 188(3): 1451-1459.
  1. 21.   C5a-regulated CCAAT/Enhancer-binding Proteins beta and delta Are Essential in Fc gamma Receptor-mediated Inflammatory Cytokine and Chemokine Production in Macrophages
  2. Yan, C. G.; Zhu, M.; Staiger, J.; Johnson, P. F.; Gao, H. W.
  3. Journal of Biological Chemistry. 2012, Jan; 287(5): 3217-3230.
  1. 22.   Vaccine Protection against Simian Immunodeficiency Virus in Monkeys Using Recombinant Gamma-2 Herpesvirus
  2. Bilello, J. P.; Manrique, J. M.; Shin, Y. C.; Lauer, W.; Li, W. J.; Lifson, J. D.; Mansfield, K. G.; Johnson, R. P.; Desrosiers, R. C.
  3. Journal of Virology. 2011, Dec; 85(23): 12708-12720.
  1. 23.   CCR6/CCR10-mediated plasmacytoid dendritic cell recruitment to inflamed epithelia after instruction in lymphoid tissues
  2. Sisirak, V.; Vey, N.; Vanbervliet, B.; Duhen, T.; Puisieux, I.; Homey, B.; Bowman, E. P.; Trinchieri, G.; Dubois, B.; Kaiserlian, D.; Lira, S. A.; Puisieux, A.; Blay, J. Y.; Caux, C.; Bendriss-Vermare, N.
  3. Blood. 2011, Nov; 118(19): 5130-5140.
  1. 24.   Filarial Lymphatic Pathology Reflects Augmented Toll-Like Receptor-Mediated, Mitogen-Activated Protein Kinase-Mediated Proinflammatory Cytokine Production
  2. Babu, S.; Anuradha, R.; Kumar, N. P.; George, P. J.; Kumaraswami, V.; Nutman, T. B.
  3. Infection and Immunity. 2011, Nov; 79(11): 4600-4608.
  1. 25.   Suppressed Type 1, Type 2, and Type 17 Cytokine Responses in Active Tuberculosis in Children
  2. Kumar, N. P.; Anuradha, R.; Suresh, R.; Ganesh, R.; Shankar, J.; Kumaraswami, V.; Nutman, T. B.; Babu, S.
  3. Clinical and Vaccine Immunology. 2011, Nov; 18(11): 1856-1864.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel